Multiple Sclerosis Clinical Trials
A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 709 clinical trials
A research study for patients who have been diagnosed with multiple sclerosis
A research study for patients who have been diagnosed with multiple sclerosis
- 706 views
- 23 Nov, 2020
- 1 location
A research study for patients who have been diagnosed with multiple sclerosis
A research study for patients who have been diagnosed with multiple sclerosis
- 317 views
- 23 Nov, 2020
- 1 location
A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy
This study will look to see if ofatumumab works and is safe in adults with relapsing multiple sclerosis (MS) who are switching from their current oral medicines (dimethyl fumarate or fingolimod
- 0 views
- 17 May, 2021
- 1 location
A PHASE IIIB MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY AND PHARMACOKINETICS OF A HIGHER DOSE OF OCRELIZUMAB IN ADULTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
The purpose of this study is to compare the effects, good or bad, of a higher dose of ocrelizumab versus the approved dose of ocrelizumab on participants with PPMS. In this study, you will get either the approved dose or a higher dose of ocrelizumab.
- 0 views
- 17 May, 2021
- 1 location
Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy (MARVEN Study)
Implantable cardioverter defibrillator (ICD) for primary prevention of mortality is an approved therapy in ischemic and nonischemic cardiomyopathy patients with left ventricular ejection fraction (EF) ≤35%. However, data from clinical trials leading to this indication in nonischemic cardiomyopathy (NICM) patients were limited. The DEFINITE [1] trial (458 patients; hazard ratio …
- 350 views
- 24 Nov, 2020
- 1 location
Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis
Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis
- 334 views
- 08 Nov, 2020
- 1 location
A study of rHIgM22 dosage in relapsing MS patients.
A study of rHIgM22 dosage in relapsing MS patients.
- 184 views
- 23 Nov, 2020
- 1 location
CLadribine tablets: Observational evaluation of effectIveness and patient-reported outcomes (PROs) in suboptimally Controlled patients previously taKing injectable disease-modifying drugs (DMDs) for relapsing forms of Multiple Sclerosis (RMS) (CLICK-MS)
tablets To assess physicians’ treatment patterns (MS treatment during the last 2 years before transition to cladribine tablets, concomitant treatment for MS, follow-up treatment in
- 50 views
- 24 Nov, 2020
- 1 location
Exploring the safety and tolerability of conversion to dose-titrated Oral Siponimod in patients with advancing forms of relapsing multiple sclerosis: A 6-month open label, multi-center Phase IIIb study (EXCHANGE) Protocol Number: CBAF312AUS02
The purpose of the study is to see how safe it is and how well you tolerate changing the MS medicine you are taking currently for your MS to siponimod (an investigational drug for MS). The results
- 61 views
- 24 Nov, 2020
- 1 location
Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.
Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.
- 358 views
- 08 Nov, 2020
- 1 location